Lysophosphatidic acid as an autocrine and paracrine mediator

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1582, Issue 1-3, 2002, Pages 270-281

  Xie, Yuhuan ^a   Gibbs, Terra C ^a   Meier, Kathryn E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adipocyte; G protein coupled receptor; Lysophosphatidic acid; Ovarian cancer; Phospholipase; Prostate cancer

Indexed keywords

GROWTH FACTOR RECEPTOR; LYSOPHOSPHATIDIC ACID;

AUTOCRINE EFFECT; CELLULAR DISTRIBUTION; HUMAN; MAMMAL CELL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTOCRINE COMMUNICATION; HUMANS; LYSOPHOSPHOLIPIDS; MODELS, BIOLOGICAL; MOLECULAR CONFORMATION; PARACRINE COMMUNICATION; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 0037162067     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(02)00181-6     Document Type: Review

References (90)

1. Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes
2. Edg-2/Bzg-1 couples to the yeast pheromone response pathway selectively in response to lysophosphatidic acid
3. Edg2 receptor functionality Giα1 coexpression and fusion protein studies
4. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species
5. The molecular pharmacology of lysophosphatidate signaling
6. 2+ mobilization in human A431 cells: Structure-activity analysis
7. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors
8. Assays for phospholipase D metabolites in mammalian cells
9. A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification
10. Molecular species analysis of lysophospholipids using high-performance liquid chromatography and argentation thin-layer chromatography
11. Production of lysophosphatidic acid by lysophospholipase D in incubated plasma of spontaneously hypertensive rats and Wistar Kyoto rats
12. Quantitative analysis of lysophosphatidic acid in human blood fractions
13. Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses
14. Acyl and alkyl ether-linked lysophosphatidic acids in the nervous system
15. Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry
16. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: Comparison of the lysophospholipid contents in malignant vs. nonmalignant ascites fluids
17. Quantitative analysis of lysophosphatidic acid in human blood fractions
18. Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma
19. Lysophosphatidic acid and ovarian cancer: A paradigm for tumorogenesis and patient management
20. Lysophosphatidic acid synthesis and release
21. Lipids, lipid modification and lipid-protein interaction in membrane budding and fission - Insights from the roles of endophilin A1 and synaptophysin in synaptic vesicle endocytosis
22. CtBP/BARS induces fission of Golgi membranes by acylating lysophosphatidic acid
23. 2
24. 2 in RBL-2H3 cells
25. A lysophospholipase D pathway in the metabolism of ether-linked lipids in brain microsomes
26. Studies of lysophospholipase D of rat liver and other tissues
27. Specificity of lysophospholipase D
28. Lysophospholipase D
29. The metabolism of lyso-platelet-activating factor (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by a calcium-dependent lysophospholipase D in rabbit kidney medulla
30. Lysophosphatidic acids produced by lysophospholipase D in mammalian serum and body fluid
31. Hyperosmotic stress rapidly generates lyso-phosphatidic acid in Chlamydomonas
32. Regulation of phospholipase D
33. 2
34. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells
35. Lipid phosphate phosphatase-1 in the regulation of lysophosphatidate signaling
36. 2+ control lysophosphatidate signaling through EDG-2 receptors
37. Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independent
38. The LPA receptors
39. Sphingosine 1-phosphate signaling in mammalian cells
40. Lysophospholipid receptors
41. Pharmacological characterization of phospholipid growth-factor receptors
42. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists
43. Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization
44. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate
45. Lysophosphatidic acid- and Gβ-dependent activation of Dictyostelium MAP kinase ERK2
46. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists
47. 12/13 subunits in neuronal cells: Induction of neurite retraction
48. Phospholipase D activity is required for actin stress fiber formation in fibroblasts
49. Activation of Rho signaling contributes to lysophosphatidic acid-induced contraction of intact ileal smooth muscle of guinea-pig
50. Development of our current understanding of bioactive lysophospholipids
51. The biologically active phospholipid, lysophosphatidic acid, induces phosphatidylcholine breakdown in fibroblasts via activation of phospholipase D. Comparison with the response to endothelin
52. Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC-3 human prostate cancer cells
53. Altered activation of phospholipase D by lysophosphatidic acid and endothelin-1 in mouse embryo fibroblasts lacking phospholipase C-γ1
54. Altered activation of phospholipase D by lysophosphatidic acid and endothelin-1 in mouse embryo fibroblasts lacking phospholipase C-γ1
55. Enhancement of lysophosphatidic acid-induced ERK phosphorylation by phospholipase D1 via the formation of phosphatidic acid
56. Differential usage of signal transduction pathways defines two types of serum response factor target gene
57. Dual actions of sphingosine-1-phosphate: Extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival
58. Regulation of expression of Edg family receptors in human prostate cancer cell lines
59. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer
60. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid
61. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility
62. Endothelial differentiation gene-2 receptor is involved in lysophosphatidic acid-dependent control of 3T3F442A preadipocyte proliferation and spreading
63. Pleiotypic mechanisms of cellular responses to biologically active lysophospholipids
64. Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate
65. Lysophosphatidic acid: G-protein signalling and cellular responses
66. Lysophosphatidic acid induction of vascular endothelial growth factor in human ovarian cancer cells
67. A new link in ovarian cancer angiogenesis: Lysophosphatidic acid and vascular endothelial growth factor expression
68. Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase
69. 2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes
70. LPA as a paracrine mediator of adipocyte growth and function
71. Malignant effusions contain lysophosphatidic acid (LPA)-like activity
72. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells
73. A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells
74. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner
75. Mitogenic signaling in androgen sensitive and insensitive prostate cancer cell lines
76. Essential role for G proteins in prostate cancer cell growth and signaling
77. Growth factor-like phospholipids generated after corneal injury
78. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin
79. Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells
80. Studies on enzymes related to diacylglycerol production in activated platelets: II. Subcellular distribution, enzymatic properties and positional specificity of diacylglycerol- and monoacylglycerol-lipases
81. The phosphatidylinositol cycle and the regulation of arachidonic acid production
82. The bioactive phospholipid lysophosphatidic acid is released from activated platelets
83. Excess formation of lysophosphatidic acid with age inhibits myristic acid-induced superoxide anion generation in intact human neutrophils
84. Phosphatidic acid that accumulates in platelet-derived growth factor-stimulated Balb/c 3T3 cells is a potential mitogenic signal
85. Phospholipase D and phosphatidylcholine metabolism